Floatz logo

Sodium Salicylate

Myelodysplastic/Myeloproliferative Neoplasms

Memorial Sloan Kettering Cancer CenterSmall moleculePhase 1Dormant
CC
47/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
95/ 100

Competitive context

46 Active assets in the Myelodysplastic/Myeloproliferative Neoplasms cohort.

Asset / SponsorPhaseRating
ETOPOSIDE
M.D. Anderson Cancer Center
Phase 3BBB
Cytosin-Arabinosid
Fred Hutchinson Cancer Center
Phase 3BBB
CYCLOSPORIN A
Memorial Sloan Kettering Cancer Center
Phase 3BBB
Busulphan
Jacqueline Garcia, MD
Phase 2/3BBB
Evomela
M.D. Anderson Cancer Center
Phase 2/3BBB

View all 50 →

Same molecule, other indications

Sodium Salicylate is also rated in:

leukemiaDormant
CC
Indicative ·
40 / 100
View asset →
myelodysplastic syndromeDormant
CC
Indicative ·
40 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →